These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 31863151

  • 1. Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function.
    Gnocchi D, Kapoor S, Nitti P, Cavalluzzi MM, Lentini G, Denora N, Sabbà C, Mazzocca A.
    J Mol Med (Berl); 2020 Feb; 98(2):179-191. PubMed ID: 31863151
    [Abstract] [Full Text] [Related]

  • 2. Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth.
    Gnocchi D, Cavalluzzi MM, Mangiatordi GF, Rizzi R, Tortorella C, Spennacchio M, Lentini G, Altomare A, Sabbà C, Mazzocca A.
    ChemMedChem; 2021 Jul 06; 16(13):2121-2129. PubMed ID: 33831272
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma.
    Gnocchi D, Kurzyk A, Mintrone A, Lentini G, Sabbà C, Mazzocca A.
    Biochimie; 2022 Nov 06; 202():180-189. PubMed ID: 35952946
    [Abstract] [Full Text] [Related]

  • 4. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
    Sokolov E, Eheim AL, Ahrens WA, Walling TL, Swet JH, McMillan MT, Simo KA, Thompson KJ, Sindram D, McKillop IH.
    J Surg Res; 2013 Mar 06; 180(1):104-13. PubMed ID: 23182454
    [Abstract] [Full Text] [Related]

  • 5. Proscillaridin A inhibits hepatocellular carcinoma progression through inducing mitochondrial damage and autophagy.
    Luo M, Liu Y, Liu N, Shao W, Ming L, Liu J, Xie Y.
    Acta Biochim Biophys Sin (Shanghai); 2021 Jan 12; 53(1):19-28. PubMed ID: 33201987
    [Abstract] [Full Text] [Related]

  • 6. Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma.
    Mazzocca A, Dituri F, De Santis F, Filannino A, Lopane C, Betz RC, Li YY, Mukaida N, Winter P, Tortorella C, Giannelli G, Sabbà C.
    Cancer Res; 2015 Feb 01; 75(3):532-43. PubMed ID: 25589345
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice.
    Gnocchi D, Afonso MB, Cavalluzzi MM, Lentini G, Ingravallo G, Sabbà C, Rodrigues CMP, Mazzocca A.
    Mol Carcinog; 2023 May 01; 62(5):577-582. PubMed ID: 36752344
    [Abstract] [Full Text] [Related]

  • 8. A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells.
    Lippolis R, Gnocchi D, Santacroce L, Siciliano RA, Mazzeo MF, Scacco S, Sabbà C, Mazzocca A.
    Biochem Biophys Res Commun; 2020 Jun 11; 526(4):1150-1156. PubMed ID: 32321639
    [Abstract] [Full Text] [Related]

  • 9. Thiostrepton as a Potential Therapeutic Agent for Hepatocellular Carcinoma.
    Su G, Yang Q, Zhou H, Huang Y, Nie S, Wang D, Ma G, Zhang S, Kong L, Zou C, Li Y.
    Int J Mol Sci; 2024 Sep 08; 25(17):. PubMed ID: 39273665
    [Abstract] [Full Text] [Related]

  • 10. Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway.
    Zhang W, Wu J, Zhou L, Xie HY, Zheng SS.
    Indian J Exp Biol; 2010 Dec 08; 48(12):1167-74. PubMed ID: 21250597
    [Abstract] [Full Text] [Related]

  • 11. Treatment with a New Barbituric Acid Derivative Exerts Antiproliferative and Antimigratory Effects against Sorafenib Resistance in Hepatocellular Carcinoma.
    Liao YJ, Hsu SM, Chien CY, Wang YH, Hsu MH, Suk FM.
    Molecules; 2020 Jun 20; 25(12):. PubMed ID: 32575795
    [Abstract] [Full Text] [Related]

  • 12. A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator.
    Zheng X, Jia Y, Qiu L, Zeng X, Xu L, Wei M, Huang C, Liu C, Chen L, Han J.
    J Biol Chem; 2020 Feb 07; 295(6):1474-1488. PubMed ID: 31914406
    [Abstract] [Full Text] [Related]

  • 13. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL, Zeng J, Chen YL, He PM, Wen MX, Ren MD, Hu YN, Lu GF, He SΧ.
    Int J Oncol; 2013 Jan 07; 42(1):229-38. PubMed ID: 23165705
    [Abstract] [Full Text] [Related]

  • 14. Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma.
    Baek SY, Hwang UW, Suk HY, Kim YW.
    Biomolecules; 2020 May 04; 10(5):. PubMed ID: 32375410
    [Abstract] [Full Text] [Related]

  • 15. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J, Chen X, Lin W, Wu G, Zhuang Q, Zhong X, Hong Z, Peng J.
    Int J Oncol; 2013 Mar 04; 42(3):971-8. PubMed ID: 23338043
    [Abstract] [Full Text] [Related]

  • 16. RNA interference against cancer/testis genes identifies dual specificity phosphatase 21 as a potential therapeutic target in human hepatocellular carcinoma.
    Deng Q, Li KY, Chen H, Dai JH, Zhai YY, Wang Q, Li N, Wang YP, Han ZG.
    Hepatology; 2014 Feb 04; 59(2):518-30. PubMed ID: 23929653
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor.
    Lou L, Chen YX, Jin L, Li X, Tao X, Zhu J, Chen X, Wu S, Ye W, He J, Ding G.
    J Int Med Res; 2013 Feb 04; 41(1):55-63. PubMed ID: 23569130
    [Abstract] [Full Text] [Related]

  • 18. Pogostemon cablin Triggered ROS-Induced DNA Damage to Arrest Cell Cycle Progression and Induce Apoptosis on Human Hepatocellular Carcinoma In Vitro and In Vivo.
    Huang XF, Sheu GT, Chang KF, Huang YC, Hung PH, Tsai NM.
    Molecules; 2020 Nov 30; 25(23):. PubMed ID: 33266043
    [Abstract] [Full Text] [Related]

  • 19. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
    Zhang X, Ma J, Song N, Guo Y, Hui L, Sang C.
    Pharmacology; 2020 Nov 30; 105(11-12):705-714. PubMed ID: 32062649
    [Abstract] [Full Text] [Related]

  • 20. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells.
    Kim YW, Jang EJ, Kim CH, Lee JH.
    Chem Biol Interact; 2017 Jan 05; 261():108-117. PubMed ID: 27871897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.